— Know what they know.
Not Investment Advice

IRTC NASDAQ

iRhythm Technologies, Inc.
1W: +8.7% 1M: +9.9% 3M: +1.1% YTD: -29.4% 1Y: -31.5% 3Y: +50.6% 5Y: +74.8%
$123.75
+1.82 (+1.49%)
 
Weekly Expected Move ±5.0%
$109 $115 $121 $127 $134
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 70 · $4.1B mcap · 30M float · 1.89% daily turnover · Short 64% of daily vol
Credit Risk of going bust: lower than 61% of companies Debt: 15.1% of company value Bonds: $39.8M held by 21 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.78 (down 99%), iRhythm Technologies, Inc. would be worth roughly what it owes.
Total debt $727.3M against a stock market value of $4.08B.
Distance to default 6.31 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $327.1M (short-term plus half of long-term), stock volatility 43.6%; Altman Z 3.02. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-03-08
Earliest Filing
2024-09-04
Latest Filing
partner: 2 investor: 1

Counterparties (Filed by IRTC)

3 relationships

Companies named in IRTC's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
BioIntelliSense, Inc. — partner iRhythm entered into a Technology License Agreement and purchased convertible promissory notes from BioIntelliSense. 2024-09-04 View
Goldman Sachs & Co. LLC GSCE investor Initial Purchaser in the private placement of Convertible Senior Notes 2024-03-08 View
U.S. Bank Trust Company, National Association — partner Trustee for the Indenture governing the Convertible Senior Notes 2024-03-08 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-05 Regulation FD; Exhibits View
2026-09-22 Regulation FD View
2026-08-13 Officer/Director Change View
2026-08-06 Material Agreement; Earnings Release; Regulation FD; Exhibits Agreement View
2026-08-06 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-06-15 Other Events View
2026-06-05 Regulation FD; Exhibits View
2026-05-28 Officer/Director Change; Shareholder Vote; Exhibits View
2026-04-30 Earnings Release; Exhibits View
2026-04-01 Accountant Change; Exhibits View
2026-03-12 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2026-02-19 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-10-30 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Departure/E Agreement View
2025-07-31 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-07 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-05-30 Submission of Matters to a Vote of Security Holders View
2025-05-01 Financial Statements and Exhibits View
2025-02-20 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-27 Departure/Election of Directors; Appointment of Officers View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms